National Healthcare (NHC) EBITDA (2010 - 2026)

National Healthcare (NHC) has reported EBITDA for 17 consecutive years, with $32.3 million the latest figure, recorded in Q1 2026.

• EBITDA for Q1 2026 came in at $32.3 million, up 4.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $129.8 million (up 23.67% YoY), and the FY2025 annual result was $128.4 million, up 42.78% from the prior year.
• EBITDA was $32.3 million for Q1 2026 at National Healthcare, down from $33.1 million in the prior quarter.
• Over five years, EBITDA peaked at $34.1 million in Q2 2025 and troughed at -$17.1 million in Q4 2022.
• Average EBITDA over 5 years is $18.5 million, with a median of $20.4 million recorded in 2023.
• Year-over-year, EBITDA plunged 68.05% in 2022 and surged 219.4% in 2023.
• Over 5 years, EBITDA stood at -$17.1 million in 2022, then jumped by 219.37% to $20.4 million in 2023, then jumped by 41.42% to $28.9 million in 2024, then advanced by 14.55% to $33.1 million in 2025, then retreated by 2.61% to $32.3 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $32.3 million in Q1 2026, $33.1 million in Q4 2025, and $30.4 million in Q3 2025.